Optivate® (Human Coagulation Factor VIII)

BIOLOGICAL5 trials

Sponsors

Bio Products Laboratory

Conditions

Haemophilia AVon Willebrand DiseasevonWillebrand's Disease

Phase 2

A Study to Compare the Pharmacokinetics and Safety of Optivate® and Haemate P® in Patients With Von Willebrand Disease.

CompletedNCT02250508

Bio Products LaboratoryvonWillebrand's Disease

Start: 2004-12-31Updated: 2018-02-15

Phase 3

A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

CompletedNCT02246881

Bio Products LaboratoryVon Willebrand Disease

Start: 2001-10-31Updated: 2018-02-15

An Open Study to Investigate the Safety and Efficacy of Optivate® in Severe Haemophilia A Patients.

CompletedNCT02246868

Bio Products LaboratoryHaemophilia A

Start: 2001-09-30Updated: 2018-02-15

A Study to Investigate the Safety and Efficacy of Optivate® in Children Under 6 Years of Age With Haemophilia A.

CompletedNCT02246894

Bio Products LaboratoryHaemophilia A

Start: 2003-11-30Updated: 2018-02-15

An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.

CompletedNCT02250482

Bio Products LaboratoryHaemophilia A

Start: 2001-11-30Updated: 2018-02-15